Continued spending on R&D activities
First written in FY2017-Q1. 14 of 33 entries say "Restated". Latest entry: FY2026.
36 other companies' latest entry also says "Other".
- FY2026Annual research and development expenses decreased to ¥697,721 thousandAnnual report
「The total R&D expenses for the consolidated fiscal year were ¥697.721 million. (All expenses related to the food manufacturing and sales business.)」
Annual R&D expenses were ¥697.721 million, down from ¥702.644 million in the previous fiscal year. - FY2026-H1Interim-period R&D expenses increased to ¥327 millionAnnual report
「The amount of the Group's R&D activities during the interim consolidated accounting period was ¥327 million.」
Interim-period R&D expenses were ¥327 million, up from ¥303 million in the same interim period of the previous year. It was stated that there had been no material changes in the status of R&D activities. - FY2025-H1Interim-period R&D expenses increased to ¥319 millionAnnual report
「The amount of the Group's R&D activities during the interim consolidated accounting period was ¥319 million.」
Interim-period R&D expenses were ¥319 million, up from ¥303 million in the same interim period of the previous year. It was stated that there had been no material changes in the status of R&D activities. - FY2024Annual R&D expenses increased to ¥666.453 millionAnnual report
「The total R&D expenses for the consolidated fiscal year were ¥666.453 million. (All expenses related to the food manufacturing and sales business.)」
Annual R&D expenses were ¥666.453 million, up from ¥628.847 million in the previous fiscal year. - FY2024-Q3Cumulative research and development expenses decreased to ¥483 millionAnnual report
「The amount of research and development activities for the Group as a whole during the third quarter of the current consolidated cumulative period was ¥483 million. There were no material changes in the status of the Group's research and development activities during the third quarter of the current consolidated cumulative period.」
Cumulative research and development expenses were ¥483 million, a slight decrease from ¥484 million in the same period of the previous year. It was stated that there had been no material changes in the status of research and development activities. - FY2024-Q2Cumulative research and development expenses increased to ¥303 millionAnnual report
「The amount of research and development activities for the Group as a whole during the second quarter of the current consolidated cumulative period was ¥303 million.」
Cumulative research and development expenses were ¥303 million, up from ¥300 million in the same period of the previous year. It was stated that there had been no material changes in the status of research and development activities. - FY2024-Q1Quarterly research and development expenses increased to ¥172 millionAnnual report
「The amount of research and development activities for the Group as a whole during the first quarter of the current consolidated cumulative period was ¥172 million. There were no material changes in the status of the Group's research and development activities during the first quarter of the current consolidated cumulative period.」
Research and development expenses increased from ¥171 million in the same period of the previous year to ¥172 million. It was stated that there had been no material changes in the status of research and development activities. - FY2023Annual research and development expenses decreased to ¥628 millionAnnual report
「The total research and development expenses for the Group as a whole during the current consolidated fiscal year were ¥628,847 thousand. (All related to the food manufacturing and sales business.)」
Annual research and development expenses were ¥628,847 thousand, down from ¥649,774 thousand in the previous fiscal year. Research and development activities are concentrated in the food manufacturing and sales business. - FY2023-Q3Cumulative research and development expenses increased to ¥484 millionAnnual report
「The amount of research and development activities for the Group as a whole during the third quarter of the current consolidated cumulative period was ¥484 million.」
Cumulative research and development expenses were ¥484 million, up from ¥477 million in the same period of the previous year. It was stated that there had been no material changes in the status of research and development activities. - FY2023-Q2Cumulative research and development expenses increased to ¥300 millionAnnual report
「The amount of research and development activities for the Group as a whole during the second quarter of the current consolidated cumulative period was ¥300 million.」
Cumulative research and development expenses were ¥300 million, up from ¥298 million in the same period of the previous year. It was stated that there had been no material changes in the status of research and development activities. - FY2023-Q1Quarterly research and development expenses decreased to ¥167 millionAnnual report
「The amount of research and development activities for the Group as a whole during the first quarter of the current consolidated cumulative period was ¥167 million.」
Research and development expenses decreased from ¥171 million in the same period of the previous year to ¥167 million. It was stated that there had been no material changes in the status of research and development activities. - FY2022-Q3Cumulative research and development expenses increased to ¥477 millionAnnual report
「The amount of research and development activities for the Group as a whole during the third quarter of the current consolidated cumulative period was ¥477 million.」
Cumulative research and development expenses were ¥477 million, up from ¥440 million in the same period of the previous year. It was stated that there had been no material changes in the status of research and development activities. - FY2022-Q2Cumulative research and development expenses increased to ¥298 millionAnnual report
「The amount of research and development activities for the Group as a whole during the second quarter of the current consolidated cumulative period was ¥298 million.」
Cumulative research and development expenses were ¥298 million, up from ¥258 million in the same period of the previous year. It was stated that there had been no material changes in the status of research and development activities. - FY2022-Q1Quarterly research and development expenses increased to ¥171 millionAnnual report
「The amount of research and development activities for the Group as a whole during the first quarter of the current consolidated cumulative period was ¥171 million.」
Research and development expenses increased from ¥156 million in the same period of the previous year to ¥171 million. It was stated that there had been no material changes in the status of research and development activities. - FY2021-Q3Cumulative quarterly research and development expenses increased to ¥440 millionAnnual report
「The amount of research and development activities for the Group as a whole during the third quarter of the current consolidated cumulative period was ¥440 million.」
Research and development expenses increased from ¥396 million in the same period of the previous year to ¥440 million. It was stated that there had been no material changes in the status of research and development activities. - FY2021-Q2Cumulative quarterly research and development expenses increased to ¥273 millionAnnual report
「The amount of research and development activities for the Group as a whole during the second quarter of the current consolidated cumulative period was ¥273 million.」
Research and development expenses were ¥273 million, up from ¥258 million in the same period of the previous year. It was stated that there had been no material changes in the status of research and development activities. - FY2021-Q1Quarterly research and development expenses increased to ¥156 millionAnnual report
「The amount of research and development activities for the Group as a whole during the first quarter of the current consolidated cumulative period was ¥156 million.」
Research and development expenses were ¥156 million, up from ¥143 million in the same period of the previous year. It was stated that there had been no material changes in the status of research and development activities. - FY2020Annual research and development expenses increased to ¥558,399 thousandAnnual report
「The total research and development expenses for the Group as a whole during the current consolidated fiscal year were ¥558,399 thousand. (All related to the food manufacturing and sales business.)」
Annual research and development expenses were ¥558,399 thousand, up from ¥525,596 thousand in the previous fiscal year. - FY2020-Q3RestatedAnnual report
「The amount of research and development activities for the Group as a whole during the third quarter of the current consolidated cumulative period was ¥418 million. There were no material changes in the status of the Group's research and development activities during the third quarter of the current consolidated cumulative period.」
Research and development expenses of ¥418 million were recorded, and it was stated that there had been no material changes in the status of research and development activities. - FY2020-Q2RestatedAnnual report
「The amount of research and development activities for the Group as a whole during the second quarter of the current consolidated cumulative period was ¥258 million. There were no material changes in the status of the Group's research and development activities during the second quarter of the current consolidated cumulative period.」
Research and development expenses of ¥258 million were recorded, and it was stated that there had been no material changes in the status of research and development activities. - FY2020-Q1RestatedAnnual report
「The amount of research and development activities for the Group as a whole during the first quarter of the current consolidated cumulative period was ¥143 million. There were no material changes in the status of the Group's research and development activities during the first quarter of the current consolidated cumulative period.」
Research and development expenses of ¥143 million were recorded, and it was stated that there had been no material changes in the status of research and development activities. - FY2019RestatedAnnual report
「The total research and development expenses for the Group as a whole during the current consolidated fiscal year were ¥525,596 thousand.」
Research and development activities continued, and annual research and development expenses of ¥525,596 thousand were recorded. - FY2019-Q3RestatedAnnual report
「The amount of research and development activities for the Group as a whole during the third quarter of the current consolidated cumulative period was ¥396 million. There were no material changes in the status of the Group's research and development activities during the third quarter of the current consolidated cumulative period.」
Research and development expenses were ¥396 million, and it was stated that there had been no material changes in the status of research and development activities. - FY2019-Q2RestatedAnnual report
「The amount of research and development activities for the Group as a whole during the second quarter of the current consolidated cumulative period was ¥249 million. There were no material changes in the status of the Group's research and development activities during the second quarter of the current consolidated cumulative period.」
Research and development expenses of ¥249 million were recorded, and it was stated that there had been no material changes in the status of research and development activities. - FY2019-Q1RestatedAnnual report
「The amount of research and development activities for the Group as a whole during the first quarter of the current consolidated cumulative period was ¥144 million. There were no material changes in the status of the Group's research and development activities during the first quarter of the current consolidated cumulative period.」
Research and development expenses of ¥144 million were recorded, and it was stated that there had been no material changes in the status of research and development activities. - FY2018RestatedAnnual report
「The total research and development expenses for the Group as a whole during the current consolidated fiscal year were ¥543,995 thousand.」
Research and development activities continued, and annual research and development expenses of ¥543,995 thousand were recorded. Activities involving new technologies, new products, product evaluation and basic research also continued. - FY2018-Q3RestatedAnnual report
「The amount of research and development activities for the Group as a whole during the third quarter of the current consolidated cumulative period was ¥414 million. There were no material changes in the status of the Group's research and development activities during the third quarter of the current consolidated cumulative period.」
Research and development expenses of ¥414 million were recorded, and it was stated that there had been no material changes in the status of research and development activities. - FY2018-Q2RestatedAnnual report
「The amount of research and development activities for the Group as a whole during the second quarter of the current consolidated cumulative period was ¥247 million. There were no material changes in the status of the Group's research and development activities during the second quarter of the current consolidated cumulative period.」
Research and development expenses of ¥247 million were recorded, and it was stated that there had been no material changes in the status of research and development activities. - FY2018-Q1RestatedAnnual report
「The amount of research and development activities for the Group as a whole during the first quarter of the current consolidated cumulative period was ¥141 million. There were no material changes in the status of the Group's research and development activities during the first quarter of the current consolidated cumulative period.」
Research and development expenses of ¥141 million were recorded, and it was stated that there had been no material changes in the status of research and development activities. - FY2017RestatedAnnual report
「The total research and development expenses for the Group as a whole during the current consolidated fiscal year were ¥526,047 thousand.」
Research and development activities continued, and annual research and development expenses of ¥526,047 thousand were recorded. Details of activities involving new technologies, new products, safety assessments and basic research were also provided. - FY2017-Q3RestatedAnnual report
「The amount of research and development activities for the Group as a whole during the third quarter of the current consolidated cumulative period was ¥388 million. There were no material changes in the status of the Group's research and development activities during the third quarter of the current consolidated cumulative period.」
Research and development expenses were ¥388 million, and it was stated that there had been no material changes in the status of research and development activities. - FY2017-Q2RestatedAnnual report
「The amount of research and development activities for the Group as a whole during the second quarter of the current consolidated cumulative period was ¥241 million. There were no material changes in the status of the Group's research and development activities during the second quarter of the current consolidated cumulative period.」
Research and development expenses were ¥241 million, and it was stated that there had been no material changes in the status of research and development activities. - FY2017-Q1First statedAnnual report
「The amount of research and development activities for the Group as a whole during the first quarter of the current consolidated cumulative period was ¥132 million.」
Research and development expenses were ¥132 million for the quarter, and it was stated that there had been no material changes in the status of research and development activities.